Literature DB >> 27548865

Effectiveness of a Sensory-Enriched Early Intervention Group Program for Children With Developmental Disabilities.

Erna Imperatore Blanche1, Megan C Chang2, Juliana Gutiérrez3, Janet S Gunter4.   

Abstract

OBJECTIVE: The study's objective was to evaluate the effectiveness of the Interdisciplinary Sensory-Enriched Early Intervention (ISEEI) group program for children with developmental delays.
METHOD: We conducted a retrospective chart review of 63 children ages 18-36 mo who participated in ISEEI. We evaluated participants with the Bayley Scales of Infant and Toddler Development III (Bayley-III) and the Infant/Toddler Sensory Profile (ITSP) at enrollment and after 3-9 mo. We conducted a paired t test to examine changes in the Bayley-III between pre- and posttests.
RESULTS: At enrollment, 70% of children presented atypical scores in two or more areas of sensory processing in the ITSP. Results revealed that children with sensory processing difficulties demonstrated significant improvement in all areas of development except fine motor skills; children without sensory processing difficulties showed significant improvement in language and cognition.
CONCLUSION: The ISEEI group program is an effective method to ameliorate developmental delays.
Copyright © 2016 by the American Occupational Therapy Association, Inc.

Entities:  

Year:  2016        PMID: 27548865     DOI: 10.5014/ajot.2016.018481

Source DB:  PubMed          Journal:  Am J Occup Ther        ISSN: 0272-9490


  2 in total

Review 1.  Care of girls and women with Turner syndrome: beyond growth and hormones.

Authors:  Caroline Culen; Diana-Alexandra Ertl; Katharina Schubert; Lisa Bartha-Doering; Gabriele Haeusler
Journal:  Endocr Connect       Date:  2017-03-23       Impact factor: 3.335

2.  ESSENCE-Q - used as a screening tool for neurodevelopmental problems in public health checkups for young children in south Japan.

Authors:  Yuhei Hatakenaka; Hitoshi Ninomiya; Eva Billstedt; Elisabeth Fernell; Christopher Gillberg
Journal:  Neuropsychiatr Dis Treat       Date:  2017-05-10       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.